The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
Carwyn Jones will try to focus Labour members' attention on their party's achievements in Wales in what could be a tense conference.
Much of Wales again enjoying a fabulous day with warm sunshine! A little cooler in the west where the mist and low cloud will linger!
Delyth Thomas, aged 56, was overwhelmed when her cat Chloe walked back into her house in Skewen after four years.